Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
about
In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahiiInfluence of verapamil on pharmacokinetics of pristimerin in rats.Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies.Comparative Proteome Analysis in Schizosaccharomyces pombe Identifies Metabolic Targets to Improve Protein Production and Secretion.Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail.Management of chronic vulvovaginal candidiasis: a long term retrospective study.Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.The use of aromatase inhibitors in boys with short stature: what to know before prescribing?Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals.Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
P2860
Q28550113-5213723E-632E-4575-BDB0-7E32CD5DEFAAQ35766574-3A2B95E1-4EE2-4BC6-8274-D3A20D5368C2Q36072448-1DF7F6E9-52AF-469D-81FE-C0EA6FCC322DQ36091284-C35F05EC-3767-4666-A157-7E0DD58E3DF9Q37038199-DA868BDE-1809-423A-84B6-C9E15E0A02FBQ39669983-961A99DE-3B92-4ADA-8D64-1038B625EE4BQ39718338-F7450ABA-B8D5-4751-AF06-600E4CF25442Q40322487-1019E4ED-15CF-4E81-8DEC-8BADD6D36ADDQ47700487-E0E2D440-C248-4451-8AC7-DEE8F0CDA458Q47804787-FBB5C687-9E4F-46E0-878D-2F82CA3BC53EQ50924228-7A6562F7-7933-4610-9CDC-6E7CCED6B1F2Q52729171-E5BCD6A4-0BF5-4BFB-BCAD-0582D2036CD1Q52777337-5C838D2D-D3E9-44C0-88AA-4515FA06A4B6Q53117928-8535C04D-C64C-45FA-9C1F-D627AF3C67AA
P2860
Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Drug interactions between nine ...... zed by human cytochromes P450.
@en
type
label
Drug interactions between nine ...... zed by human cytochromes P450.
@en
prefLabel
Drug interactions between nine ...... zed by human cytochromes P450.
@en
P2093
P1476
Drug interactions between nine ...... zed by human cytochromes P450.
@en
P2093
Hiroshi Yamazaki
Toshiro Niwa
Yurie Imagawa
P304
P356
10.2174/1389200215666141125121511
P407
P577
2014-01-01T00:00:00Z